tradingkey.logo
tradingkey.logo
Search

Phibro Animal Health Corp

PAHC
Add to Watchlist
36.330USD
-0.120-0.33%
Close 07-31 16:00ETQuotes delayed by 15 min
1.47BMarket Cap
15.46P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-07-31
Previous score
6.00
Change
0
The current earnings forecast score of Phibro Animal Health Corp is 6.00, ranking 132 out of 155 in the Pharmaceuticals industry. The average price target is 45.00, with a high of 50.00 and a low of 32.00.

Analyst Rating

Based on 5 analysts
Hold
Current Rating
41.750
Target Price
+14.92%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Phibro Animal Health Corp
PAHC
5
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
32
Pfizer Inc
PFE
32
1
2
3
...
32

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is Phibro Animal Health Corp's expected revenue for the next quarter?

Phibro Animal Health Corp's expected revenue is 381.25M.

What is Phibro Animal Health Corp's price target?

Analysts forecast that Phibro Animal Health Corp's price target is USD 45.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 32.00.

How have Phibro Animal Health CorpPAHC's recent earnings per share performed?

The market expectation was USD 0.59, while Phibro Animal Health CorpPAHC's earnings per share (EPS) for the previous quarter was USD 0.68. EPS for the next quarter is expected at USD 0.71.

What is the analyst rating for Phibro Animal Health Corp?

Based on the ratings of Phibro Animal Health Corp's stock from 5 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.